Picture of Magforce AG logo

MF6 Magforce AG Share Price

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m+0.77%
3m-76.21%
6m-29.19%
1yr-16.72%
Volume Change (%)
10d/3m-24.23%
Price vs... (%)
52w High-79.59%
50d MA-14.46%
200d MA-13.4%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-23.23%
Return on Equity-33.92%
Operating Margin-1913.9%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Magforce AG EPS forecast chart

Profile Summary

Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.

Directors

Last Annual
December 31st, 2021
Last Interim
December 31st, 2021
Incorporated
October 6th, 2005
Public Since
September 21st, 2007
No. of Employees
69
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
de flag iconStuttgart Stock Exchange
Shares in Issue
29,931,738
Blurred out image of a map
Address
Max-Planck-Strasse 3, BERLIN, 12489
Web
https://www.magforce.com/
Phone
+49 303083800
Contact
Barbara von Frankenberg
Auditors
AIOS GmbH Wirtschaftsprufungsgesellshaft

MF6 Share Price Performance

Upcoming Events for MF6

Full Year 2023 Magforce AG Earnings Release

Magforce AG Annual Shareholders Meeting

Similar to MF6

Picture of Vidac Pharma Holding logo

Vidac Pharma Holding

de flag iconStuttgart Stock Exchange

FAQ